Cargando…

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus’

Detalles Bibliográficos
Autor principal: Mundra, Vishal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510940/
https://www.ncbi.nlm.nih.gov/pubmed/23226666
http://dx.doi.org/10.4103/2230-8210.103040
_version_ 1782251519175819264
author Mundra, Vishal
author_facet Mundra, Vishal
author_sort Mundra, Vishal
collection PubMed
description
format Online
Article
Text
id pubmed-3510940
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35109402012-12-05 Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus’ Mundra, Vishal Indian J Endocrinol Metab Letters to the Editor Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3510940/ /pubmed/23226666 http://dx.doi.org/10.4103/2230-8210.103040 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Mundra, Vishal
Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus’
title Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus’
title_full Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus’
title_fullStr Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus’
title_full_unstemmed Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus’
title_short Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus’
title_sort evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus’
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510940/
https://www.ncbi.nlm.nih.gov/pubmed/23226666
http://dx.doi.org/10.4103/2230-8210.103040
work_keys_str_mv AT mundravishal evaluationofvildagliptinandfixeddosecombinationofvildagliptinandmetforminonglycemiccontrolandinsulindoseoverthreemonthsinpatientswithtype2diabetesmellitus